TPB Stock Forecast & Price Target

Turning Point Brands is supported by a clear modern-oral growth thesis, with management and analysts citing strong pouch momentum, accelerating DTC trends, and improving retail distribution that could reach about 75% of c-stores by the end of 3Q26. Its Zig-Zag and Stoker’s franchises add durable brand equity and multiple expansion avenues, while FRE and ALP are positioned in a roughly $5B nicotine/white pouch category that is driving high-single-digits-plus top-line growth. Visibility has also improved as full-year EBITDA guidance established a floor, and the company’s solid cash flow, 2026 revenue estimate of about $525 million, and 2027 revenue estimate of about $587.5 million support a positive fundamental outlook.

Turning Point Brands is facing a weakening fundamental setup as CEO Graham Purdy exits and David Glazek takes over while the company is forced to narrow FY26 EBITDA guidance to $70M-$80M from $70M-$90M because of higher freight costs and delays in onshoring. The negative outlook is further reinforced by falling expectations for the modern oral nicotine opportunity, where increased competition, potential slotting-fee normalization, and elevated investment spending could pressure margins and make it harder to sustain initial distribution gains. On top of that, key structural risks remain, including declines in MST and loose-leaf tobacco consumption, regulatory uncertainty around nicotine pouches, supplier and litigation exposure, and the possibility that TPMTA approval never arrives, limiting longer-term EBITDA upside.